200
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?

&
Pages 2783-2784 | Received 09 Aug 2020, Accepted 22 Aug 2020, Published online: 13 Sep 2020
 

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.